Arrhythmias: drugs and devices:

TL;DRAbstract

Download the Issue @ a Glance podcast Subscribe to the EHJ Podcast Arrhythmias of supraventricular and ventricular origin are an important health issue due to mortality, morbidity, and the impaired quality of life of patients with which it is associated, but are also economically relevant due to the physician's visits, hospitalizations, and interventions they lead to. For certain arrhythmias such as bradycardia of different origin and ventricular tachycardia and fibrillation, the utilization of cardiac implants such as pacemakers1 and implantable cardioverter defibrillators (ICDs)2,3 has enriched our therapeutic armamentarium. As a result, these treatment options are recommended by current guidelines in defined patient populations. The ever-increasing technological complexity of these devices is matched by the shear omnipresence of electric, magnetic, and electromagnetic fields, both in every day life and at work. As electromagnetic interference potentially bears a risk for such

Chat with Paper

AI Agents for this Paper